CANNOVUM CANNABIS AG
0.49
EUR
0.00
(0.00%)
ISIN
DE000A37FUP2
Return %
Stock
S&P 500
1Y
-36.05
14.20
3Y
-73.74
81.12
5Y
-98.02
68.34
Capital Structure
EUR
•
in mil. unless spec.Working Capital
EUR
•
in mil. unless spec.Growth Rates
EUR
•
in mil. unless spec.Semi-annual Revenue
EUR
•
in mil. unless spec.Semi-annual Earnings Per Share
EUR
•
in mil. unless spec.Semi-annual Dividends Per Share
EUR
•
in mil. unless spec.Company Description
- Sector
- Health technology
- Industry
- Pharmaceuticals: major
- Address
- Berlin Germany
- IPO Date
- May 11, 2021
- Website
- cannovum.de
- Similar Companies
- Business
- Cannovum Cannabis AG is a Germany-based cannabis enterprise operating across the medical cannabis and regulated recreational cannabis sectors. Founded in 2019 and headquartered in Berlin, Germany, the company specializes in the sourcing, distribution, and supply-chain integration of cannabinoid therapeutics, alongside providing end-to-end operational solutions, cultivation technology, and infrastructure for the legal cannabis market. The company structures its commercial activities into two core business segments: Medical Cannabis and Cultivation Infrastructure and Club Solutions. In its medical cannabis division, Cannovum Cannabis AG supplies pharmaceutical-grade cannabinoid therapeutics to pharmacies, medical practitioners, and clinical distributors, offering a comprehensive product and service portfolio that includes imported and domestically distributed medical cannabis dried flowers (flos); full-spectrum extracts and standardized cannabinoid oils; pure dronabinol and cannabidiol (CBD) active pharmaceutical ingredients; Good Distribution Practice (GDP)-compliant storage and cold-chain logistics; and scientific education and advisory services for healthcare professionals. Through its cultivation infrastructure and club solutions division, developed to address the commercial opportunities arising from Germany's Cannabis Act (CanG), the company provides integrated B2B products and services tailored for non-commercial cultivation associations and cannabis social clubs (CSCs), including premium cannabis genetics, certified seeds, and starter cuttings; specialized horticultural consumables such as biological fertilizers, soil substrates, and organic crop protection systems; controlled-environment agriculture hardware, climate management, and LED lighting systems; club administration, inventory tracking, and regulatory compliance software platforms; and specialized consulting covering facility design, agronomic cultivation methods, and licensing workflows. In recent corporate developments, the company completed a formal corporate rebranding from Cannovum AG to Cannovum Cannabis AG to solidify its strategic orientation across the liberalized cannabis market. In alignment with German regulatory reforms, the company founded the Anbau-Allianz für Deutschland (Cultivation Alliance for Germany), a broad-scale strategic alliance with prominent commercial agricultural producers, horticultural specialists, and research institutes to secure domestic, sustainable, and scalable production capacities for adult-use cannabis clubs. Additionally, Cannovum Cannabis AG has entered into multi-year supply and distribution partnerships with certified European producers, launched turn-key franchise and service packages for emerging cultivation associations nationwide, and completed strategic capital measures to fund the operational expansion of its supply-chain network across Germany and neighboring European markets.